Compositions and methods for inhibiting NF-κB mediated...

Details Compositions and methods for inhibiting NF-κB mediated... Compositions and methods for inhibiting NF-κB mediated...

2011-08-02

2011-08-02

Fetterolf, Brandon J (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S519000, C514S602000, C514S708000

Reexamination Certificate

active

07989495

ABSTRACT:
Disclosed are compositions and methods for inhibiting NF-κB mediated cellular proliferation and metastasis.

REFERENCES:
patent: 7175679 (2007-02-01), Khan et al.
Biswas, Debajit K., Sun-Chun Dai, Antonio Cruz, Barbara Weiser, Edgard Graner and Arther B. Pardee. The nuclear factor kapp B (NF-kB): A potential therapeutical target for estrogen receptor. vol. 98. No. 18. 2001. 10386-10391. 6 sheets
Izban et al. Constitutive Expression of NF-kappaB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Human Pathology. vol. 31, No. 12 (Dec. 2000).
Goodman et al. [Editors] “Chapter 198: Principles of Cancer Therapy.” Cecil's Textbook Medicine (Twenty-First Edition, vol. 1). W.B. Saunders Company, 2000. pp. 1060-1074.
Lawrence et al. Possible new role for NK-kappaB in the resolution of inflammation. Nature Medicine. vol. 7, No. 12, Dec. 2001.
Alkalay et al. (1995). Stimulation-dependent I kappa B alpha phosphorylation marks the NF-B inhibitor for degradation via the ubiquitin-proteasome pathway, Proc Natl Acad Sci U S A 92; 10599-10603.
Aoudjit and Vuori, (2001). Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis, J Cell Biol 152, 633-643.
Battu et al. (1998). Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29 cl.19A, Anticancer Res 18, 2397-2403.
Beg et al. (1992). I kappa B interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention, Genes Dev 6, 1899-1913.
Boland, (1999). Malignant Tumors of the Colon. In Textbook of Gastroenterology, T. Yamada, D. H. Alpers, L. Laine, C. Owyang, and D. W. Powell, eds. (Philadelphia, Lippincott Williams and Wilkins), pp. 2023-2082.
Cao et al. (1998). Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer, Cancer Res 58, 1695-1699.
Chambers et al. (1995). Steps in tumor metastasis: new concepts from intravital videomicroscopy, Cancer Metastasis Rev 14, 279-301.
Chen et al. (1995). Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway, Genes Dev 9, 1586-1597.
Crofford et al. (1997). Involvement of nuclear factor κ B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes, Arthritis Rheum 40, 226-236.
Darmoul et al. (2001). Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2, Br J Cancer 85, 772-779.
D'Haens et al. (1999). Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial, Gastroenterology 116, 1029-1034.
DiDonato et al. 1996). Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation, Mol Cell Biol 16, 1295-1304.
DuBois et al. (1996). Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention, Gastroenterol Clin North Am 25, 773-791.
Eberhart et al. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology 107, 1183-1188.
Elder et al. (1997). Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti- inflammatory drug: independence from COX-2 protein expression, Clin Cancer Res 3, 1679-1683.
Elnemr et al. (2001). Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway, Int J Oncol 18, 311-316.
Engers and Gabbert, (2000). Mechanisms of tumor metastasis: cell biological aspects and clinical implications, J Cancer Res Clin Oncol 126, 682-692.
Frisch and Francis, (1994). Disruption of epithelial cell-matrix interactions induces apoptosis, J Cell Biol 124, 619-626.
Girl and Aggarwal, (1998). Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates, J Biol Chem 273, 14008-14014.
Golab et al. (2000). Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice, Life Sci 66, 1223-1230.
Groden et al. (1995). Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene, Cancer Res 55, 1531-1539.
Han et al. (2000). Activation of NF-κB determines the sensitivity of human colon cancer cells to TNFalpha-induced apoptosis, Biol Pharm Bull 23, 420-426.
Hansen et al. (1995). Tumor cells in blood shed from the surgical field, Arch Surg 130, 387-393.
Hansen et al. (1999). Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells, Transfusion 39, 608-615.
He et al. (1999). PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell 99, 335-345.
Henkel et al. (1993). Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-κB, Nature 365, 182-185.
Higgins et al. (1993). Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression, Proc Natl Acad Sci U S A 90, 9901-9905.
Hsi et al. 2000). Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells, Exp Cell Res 256, 563-570.
Huang et al. (2001). Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis, Oncogene 20, 4188-4197.
Ichijo et al.. (1997). Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science 275, 90-94.
Ilyas et al.. (1997). Beta-catenin mutations in cell lines established from human colorectal cancers, Proc Natl Acad Sci U S A 94, 10330-10334.
Irmler et al. (1997). Inhibition of death receptor signals by cellular FLIP, Nature 388, 190-195.
Jung et al. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion, J Clin Invest 95, 55-65.
Kreuz et al. (2001). NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling, Mol Cell Biol 21, 3964-3973.
Kutchera et al. (1996). Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect, Proc Natl Acad Sci U S A 93, 4816-4820.
Lee and Juliano, (2000). alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B- dependent pathway, Mol Biol Cell 11, 1973-1987.
Liefers et al. (1998). Micrometastases and survival in stage II colorectal cancer, N Engl J Med 339, 223-228.
Liotta et al. (1974). Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation, Cancer Res 34, 997-1004.
Martin, (1996). Normal Cells and Cancer Cells. In Molecular Oncology, J. M. Bishop, and R. A. Weinberg, eds. (New York, Scientific American), pp. 13-40.
Mehes et al. (2001). Circulating breast cancer cells are frequently apoptotic, Am J Pathol 159, 17-20.
Meredith et al. (1993). The extracellular matrix as a cell survival factor, Mol Biol Cell 4, 953-961.
Munemitsu et al. (1995). Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein, Proc Natl Acad Sci U S A 92, 3046-3050.
Newton et al. (1997). Evidence for involvement of NF-B in the transcriptional control of COX-2 gene expression by IL-1beta, Biochem Biophys Res Commun 237, 28-32.
Newton et al. (1997). Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-κB and JNK activation, FEBS Lett 418, 135-138.
Nicolson, (1991). Gene expression, cellular diversification and tumor progression to the metastatic phenotype, Bioessays 13, 337-

Affiliated with

Also associated with

Rating

Compositions and methods for inhibiting NF-κB mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for inhibiting NF-κB mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting NF-κB mediated... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2740284